Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
Midwest · Illinois
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Chicago (2,660,000 residents, 9,450,000 metro). Northwestern and Rush operate well-known obesity-medicine programs; Walgreens (HQ in Deerfield) is the dominant retail-pharmacy chain in the metro.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Chicago →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Chicago →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Chicago →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Chicago →
Chicago is a midwest-region city with a population of 2,660,000 (9,450,000 in the broader metropolitan area). Illinois expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include Northwestern Medicine, Rush University Medical Center, UChicago Medicine.
Illinois's Medicaid program is Illinois Medicaid (HealthChoice Illinois). Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.